TY - JOUR TI - Candida balanitis. Clinical and mycological study about the efficacy of a single-day oral treatment with itraconazole (400 mg) AU - Bonifaz, Alexandro AU - Tirado-Sánchez, Andrés AU - Jaramillo-Manzur, Cristina T2 - Our Dermatology Online AB - Objective: To assess the efficacy of a single dose of itraconazole (400mg/day), divided into two doses in the treatment of Candida balanitis. Material and Methods: We carried out a prospective, non-compared study in patients with clinically verified Candida balanitis and through direct examinations, stains and cultures. Each of the patients was given a treatment scheme of itraconazole 400mg/day, divided into two doses. Revisions were carried out at baseline and subsequently on days 3, 7, and 15. Results: We included 26 cases, with an average age of 43.5 years. A predominance of Candida albicans was obtained in 69.2% and the remaining were Candida non-albicans species. At the end of the treatment and follow-up for 7 days, clinical and mycological cure was obtained in 22/26 patients (84.6%). Side effects were presented in two patients (7.7%), one with moderate dyspepsia and the other with moderate headache. Conclusion: The treatment of Candida balanitis with a single dose of 400mg of oral itraconazole is effective, well tolerated and represents a new therapeutic alternative of short duration. DA - 2020/01/02/ PY - 2020 DO - 10.7241/ourd.20201.1 DP - DOI.org (Crossref) VL - 11 IS - 1 SP - 1 EP - 5 J2 - Our Dermatol Online LA - en SN - 20819390 UR - http://www.odermatol.com/issue-in-html/2020-1-1-candida/ Y2 - 2020/01/01/11:07:32 ER -